Study Information

Alliance Study ID: NCCTG-N9923

NCT Study ID (ClinicalTrials.gov): NCT00006012

Disease or Cancer Type: Lung Cancer & Mesothelioma

Alliance Study Chair: Scott Okuno, MD

Status: COMPLETED


Study Description

RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more cancer cells.

PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy before, during, and after radiation therapy in treating patients who have limited-stage small cell lung cancer.

Related Publications

For publications related to this and other clinical trials, visit the Alliance Publications Application.

Data Sources & Contacts

Related Alliance Trials